AmpliPhi Biosciences’ investigative therapy AB-PA01, in combination with antibiotics, shows significant potential to treat multi-drug resistant Pseudomonas aeruginosa infection in…
Articles by Alice Melão, MSc
Treatment with inhaled mannitol is safe and can help to improve lung function in adult patients with cystic fibrosis…
Results of the Phase 3 ARRIVAL study show that Kalydeco (ivacaftor) has the potential to modify the course…
Exposure to tobacco smoke is a key contributor to worsening lung function in young children with cystic fibrosis (CF), researchers…
Preliminary clinical trial data of three investigational next-generation CFTR correctors, being developed by Vertex Pharmaceuticals, provides the first demonstration…
Results of a Phase 2 trial showed that treatment with Spyryx’s investigative drug SPX-101 can improve lung function…
Proteostasis Therapeutics will present an update on its cystic fibrosis (CF) clinical programs — which include an amplifier, a corrector,…
Antimicrobial peptides administered as tiny nanoparticles show promise in treating bacterial infections without risking making the bacteria more resistant to…
Arrowhead Pharmaceuticals’ investigational cystic fibrosis treatment candidate ARO-ENaC can effectively target the epithelial sodium channel alpha subunit…
An advisory committee composed by experts in the field of cystic fibrosis will help to guide the design of the…